However, an epidemiological analysis of the Veterans Affairs RA (VARA) registry80 revealed that MTX was associated with a reduced risk of BW loss, whereas prednisone or anti-TNF therapies were not associated with changes in the BMI or the risk of BW loss, independent of other factors. This evidence concerns the gene TNF and rheumatoid arthritis.